AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Hans Biomed Corp.
/
2026-05-14
▲ SURGE
Hans Biomed Corp.
+21.3%
042520
KRX
Healthcare
2026-05-14
27,900
Close
23,000
Prev Close
+21.30%
Change
2.8x
Vol Ratio
Why It Surged
제공된 뉴스 기사에서 Hans Biomed Corp.(042520)와 관련된 정보를 찾을 수 없습니다.
·
제공된 뉴스 기사에서 Hans Biomed Corp.(042520)와 관련된 정보를 찾을 수 없습니다.
Related News
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
After scrapping AXN-2510, Instil Bio hunts for new drug deals
Stocktitan
2026-03-27
Harvard Bioscience shares are trading higher after the company reported preliminary Q4 results, issued FY26 outlook and outlined its long-term strategic focus areas. - Harvard Bioscience (NASDAQ:HBIO)
Benzinga
2026-02-10
Fractyl Health sets March 24 call on 2025 results, business updates
Stocktitan
2026-03-17
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
Technical Analysis
Signals
MACD Bearish
Below SMA20
Key Indicators
44.40
RSI (14)
29895.00
SMA 20
21655.12
Bollinger Lower
38134.88
Bollinger Upper
29895.00
Bollinger Mid
-3139.21
MACD
-2979.94
MACD Signal
-159.27
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Hans Biomed Corp. Surged +21.3% on 2026-05-14 — Analysis | Alpha Lenz